Generic Sweden (GENI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Nov, 2025Executive summary
Revenue grew 5.3% year-over-year in Q3 2025 to 45.3 MSEK, with gross profit up 14.7% and EBIT up 15.2%.
SaaS services drove margin improvements, supported by strong cost control and stable OPEX.
Key products like DOCS and SMS services maintained strong demand and customer retention, with new features and security enhancements.
Management changes included appointing a new CPO and CTO to strengthen product development and system robustness.
Financial highlights
Q3 2025 revenue: 45.3 MSEK (up 5.3%); gross profit: 20.3 MSEK (up 14.7%); EBIT: 10.2 MSEK (up 15.2%).
Gross margin improved to 44.8% (from 41.1%); EBIT margin rose to 22.5% (from 20.6%).
EPS for Q3: 0.66 SEK (up from 0.58 SEK); cash flow from operations: 9.7 MSEK (up from 8.7 MSEK).
For Jan–Sep 2025, revenue grew 4.5% to 134.5 MSEK; EBIT up 28.7% to 28.9 MSEK; EPS: 1.88 SEK (up from 1.47 SEK).
Cash flow from operations for Jan–Sep: 27.1 MSEK (up from 16.5 MSEK); liquidity at period end: 46.6 MSEK.
Outlook and guidance
Continued focus on SaaS growth, security, and automation to enhance customer experience and operational efficiency.
Strategic emphasis on RCS introduction and expanding secure document handling solutions.
Latest events from Generic Sweden
- Full-year revenue and profit rose, margins improved, and a higher dividend is proposed.GENI
Q4 202512 Feb 2026 - Strong EBIT growth and improved margins in Q2 2025, led by SaaS and secure communication services.GENI
Q2 202521 Aug 2025 - Record revenue and EBITDA in Q3 2024, driven by SaaS growth and strong demand.GENI
Q3 202413 Jun 2025 - Q2 2024 saw 25% revenue growth, strong customer gains, and a shift to next-gen messaging.GENI
Q2 202413 Jun 2025 - Q4 revenue up 24% and EBITDA up 66%, driven by SaaS growth and margin expansion.GENI
Q4 20245 Jun 2025 - SaaS-driven margin growth and strong DOCS adoption boost results amid CEO transition.GENI
Q1 20255 Jun 2025